NEW YORK (GenomeWeb News) – Three research teams developing molecular breast cancer diagnostic technologies at US universities have been chosen as winners of a competition aimed at helping them develop business plans to commercialize their innovations.

At total of 10 teams were selected as winners of the Breast Cancer Startup Challenge, a competition funded and led by the Avon Foundation for Women and supported by the National Cancer Institute and the Center for Advancing Innovation, the Avon Foundation said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.